HCA Healthcare stock holds firm as 2026 outlook tightens

Published on 09/18/2026 at 12:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HCA Healthcare stock closed at USD 431.50 on September 17, 2026, after a 0.57 percent rise. MarketBeat said exchange headwinds could pressure 2026 by USD 1.0 billion to USD 1.2 billion.

HCA, US42225T1079, Illustration mit AI erstellt.

HCA Healthcare stock (ISIN US42225T1079) closed at USD 431.50 on September 17, 2026, after a 0.57 percent gain from the previous close of USD 430.43. The market value was USD 92.888 billion, with volume at 1,181,844 shares and a 52-week range of USD 353.99 to USD 556.52.

Exchange pressure weighs on 2026

According to MarketBeat on September 18, 2026, HCA said exchange-related pressure could total USD 1.0 billion to USD 1.2 billion this year. The same report said state supplemental payments should deliver a net benefit of USD 300 million to USD 500 million.

MarketBeat also said insured business excluding exchange plans grew 3.2 percent in the second quarter and adjusted admissions rose 2.7 percent. That gives investors a clear split: policy pressure is real, but underlying demand still runs above zero.

Quarterly figures still matter

Yahoo Finance showed second-quarter 2026 revenue of USD 20.23 billion and earnings of USD 1.7 billion for HCA Healthcare, with profit margin at 8.40 percent. The same quote page showed an analyst average price target of USD 452.67, with the share price at USD 431.50 sitting below that average.

At the same time, the quote page listed a 52-week high of USD 556.52, so the stock still trades well below its yearly peak. The gap is a useful marker for investors watching whether the current policy debate changes the valuation story.

Stock stays below the peak

HCA Healthcare stock ended September 17, 2026, at USD 431.50 on the NYSE, with a market cap of USD 92.888 billion. The shares remain inside a wide USD 353.99 to USD 556.52 band.